Journey Medical Corporation

Journey Medical Corporation

DERM
Journey Medical CorporationUS flagNASDAQ Capital Market
7.12
USD
-0.19
- -
195.95MMarket Cap

Income Statement (USD)

APIChatGPT
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Sales/Revenue/Turnover
35
45
63
74
79
56
62
+ Sales & Services Revenue
35
45
63
74
79
56
62
- Cost of Revenue
11
15
32
31
23
21
21
+ Cost of Goods & Services
11
15
32
31
23
21
21
Gross Profit
24
30
31
43
56
35
41
+ Other Operating Income
- -
- -
- -
- -
- -
- -
- -
- Operating Expenses
19
22
56
70
55
53
49
+ Selling, General & Admin
19
22
40
59
44
40
44
+ Research & Development
- -
- -
17
11
8
10
- -
+ Other Operating Expense
- -
- -
- -
- -
4
3
4
Operating Income (Loss)
5
8
-25
-28
1
-18
-8
- Non-Operating (Income) Loss
- -
1
17
2
5
-4
3
+ Interest Expense, Net
- -
1
7
2
1
2
3
+ Interest Expense
- -
1
7
2
2
3
4
- Interest Income
- -
- -
- -
- -
- -
1
1
+ Other Non-Op (Income) Loss
- -
- -
10
- -
3
-6
- -
Pretax Income
5
7
-42
-30
-4
-15
-11
- Income Tax Expense (Benefit)
1
2
2
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
4
5
-44
-30
-4
-15
-11
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
4
5
-44
-30
-4
-15
-11
- Minority Interest
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
4
5
-44
-30
-4
-15
-11
- Preferred Dividends
- -
- -
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
4
5
-44
-30
-4
-15
-11
EBIT
5
8
-25
-28
1
-18
-8
EBITDA
7
9
-23
-23
5
-15
-4
EBITDA Margin (%)
18.68
21.03
-36.08
-31.43
6.22
-26.21
-6.19
EBITA
5
8
-25
-28
1
-18
-8
Gross Margin (%)
69.84
67.23
49.18
58.23
71.09
62.81
66.17
Operating Margin (%)
15.06
17.63
-40.14
-37.35
1.35
-32.48
-13.21
Profit Margin (%)
10.38
11.86
-69.68
-40.22
-4.87
-26.14
-18.48
Sales per Employee
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
1
2
3
4
4
4
4
Basic Weighted Avg Shares
16
9
10
18
18
20
24
Basic EPS, GAAP
0.22
0.58
-4.32
-1.69
-0.21
-0.72
-0.47
Basic EPS from Cont Ops
0.22
0.58
-4.32
-1.69
-0.21
-0.72
-0.47
Diluted Weighted Avg Shares
16
9
10
18
18
20
24
Diluted EPS, GAAP
0.22
0.58
-4.32
-1.69
-0.21
-0.72
-0.47
Diluted EPS from Cont Ops
0.22
0.58
-4.32
-1.69
-0.21
-0.72
-0.47

Balance Sheet (USD)

APIChatGPT
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Total Current Assets
25
35
84
78
56
48
67
+ Cash, Cash Equivalents & STI
5
8
49
32
27
20
24
+ Cash & Cash Equivalents
5
8
49
32
27
20
24
+ ST Investments
- -
- -
- -
- -
- -
- -
- -
+ Accounts & Notes Receiv
19
24
23
28
15
10
30
+ Accounts Receivable, Net
19
24
23
28
15
10
30
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
- -
- -
- -
+ Inventories
1
1
10
14
10
14
10
+ Raw Materials
- -
- -
6
6
5
3
3
+ Work In Process
- -
- -
- -
- -
1
- -
- -
+ Finished Goods
1
1
4
8
5
11
7
+ Inventory Adjustments
- -
- -
- -
- -
- -
-1
-1
+ Other Inventory
- -
- -
- -
- -
- -
- -
- -
+ Other ST Assets
1
2
2
3
4
3
3
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
9
17
13
27
20
32
28
+ Property, Plant & Equip, Net
- -
- -
- -
- -
- -
- -
- -
+ Property, Plant & Equip
- -
- -
- -
- -
- -
- -
- -
- Accumulated Depreciation
- -
- -
- -
- -
- -
- -
- -
+ LT Investments & Receivables
- -
- -
- -
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
- -
- -
- -
+ Other LT Assets
9
16
13
27
20
32
28
+ Total Intangible Assets
7
15
13
27
20
32
28
+ Goodwill
- -
- -
- -
- -
- -
- -
- -
+ Other Intangible Assets
7
15
13
27
20
32
28
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
1
1
- -
- -
- -
- -
- -
Total Assets
34
52
97
105
77
80
95
+ Payables & Accruals
14
18
40
50
31
28
30
+ Accounts Payable
2
2
23
37
18
16
9
+ Accrued Taxes
- -
- -
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
12
16
16
13
13
12
21
+ ST Debt
- -
- -
1
3
- -
- -
- -
+ ST Borrowings
- -
- -
1
3
- -
- -
- -
+ ST Finance Leases
- -
- -
- -
- -
- -
- -
- -
+ Other ST Liabilities
7
10
11
14
11
7
8
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
7
10
11
14
11
7
8
Total Current Liabilities
21
28
52
67
42
35
37
+ LT Debt
5
5
- -
20
15
25
25
+ LT Borrowings
5
5
- -
20
15
25
25
+ LT Finance Leases
- -
- -
- -
- -
- -
- -
- -
+ Other LT Liabilities
5
8
4
1
- -
- -
- -
+ Accrued Liabilities
- -
- -
- -
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
5
8
4
1
- -
- -
- -
Total Noncurrent Liabilities
10
14
4
21
15
25
25
Total Liabilities
31
42
55
88
56
60
63
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
- -
- -
- -
+ Share Capital & APIC
3
5
81
85
93
107
130
+ Common Stock
- -
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
3
5
81
85
93
107
130
- Treasury Stock
- -
- -
- -
- -
- -
- -
- -
+ Retained Earnings
- -
5
-39
-69
-72
-87
-98
+ Other Equity
- -
- -
- -
- -
- -
- -
- -
Equity Before Minority Interest
3
10
42
17
20
20
32
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
- -
Total Equity
3
10
42
17
20
20
32
Total Liabilities & Equity
34
52
97
105
77
80
95
Shares Outstanding
16
16
17
18
19
22
27
Number of Employees
- -
- -
- -
- -
- -
- -
- -
Capital Leases - Total
- -
- -
- -
- -
- -
- -
- -
Net Debt
- -
-3
-48
-9
-13
5
1
Net Debt to Equity
15.23
-29.4
-114.81
-54.35
-62.98
22.79
3.73
Tangible Common Equity Ratio
-17.46
-12.85
34.81
-13.1
0.11
-24.38
6.34
Current Ratio
1.21
1.26
1.64
1.16
1.35
1.37
1.79
Cash Conversion Cycle
- -
155.04
85.68
-44.9
-236.9
49.48
45.9

Cash Flow Statement (USD)

APIChatGPT
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
+ Net Income
4
5
-44
-30
-4
-15
-11
+ Depreciation & Amortization
1
2
3
4
4
4
4
+ Non-Cash Items
1
1
25
6
7
6
7
+ Stock-Based Compensation
- -
- -
2
4
3
6
6
+ Deferred Income Taxes
- -
- -
2
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
4
1
- -
+ Other Non-Cash Adj
- -
1
20
1
1
-1
- -
+ Chg in Non-Cash Work Cap
3
-2
15
6
-2
-4
-12
+ (Inc) Dec in Accts Receiv
-10
-5
1
-5
13
4
-19
+ (Inc) Dec in Inventories
- -
-1
-8
2
4
-4
5
+ (Inc) Dec in Prepaid Assets
- -
-1
-1
-1
- -
- -
- -
+ Inc (Dec) in Accts Payable
14
4
23
11
-18
-4
3
+ Inc (Dec) in Other
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
9
5
-2
-14
5
-9
-12
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
-2
-1
-10
-20
-5
-15
- -
+ Acq of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
+ Acq of Intangible Assets
-2
-1
-10
-20
-5
-15
- -
+ Cash (Repurchase) of Equity
- -
- -
33
- -
4
- -
- -
+ Increase in Capital Stock
- -
- -
33
- -
4
- -
- -
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
- -
+ Net Change in LT Investment
- -
- -
- -
- -
- -
- -
- -
+ Dec in LT Investment
- -
- -
- -
- -
- -
- -
- -
+ Inc in LT Investment
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
-2
-1
-10
-20
-5
-15
- -
+ Dividends Paid
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
-4
- -
5
17
-4
17
16
+ Cash From Debt
- -
- -
17
25
47
18
16
+ Repayments of Debt
-4
- -
-11
-8
-52
-1
-1
+ Other Financing Activities
- -
- -
15
- -
-5
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
-4
- -
53
16
-5
17
16
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
- -
Net Changes in Cash
3
3
41
-17
-5
-7
4
EBITDA
7
9
-23
-23
5
-15
-4
EBITDA Margin (%)
18.68
21.03
-36.08
-31.43
6.22
-26.21
-6.19
Free Cash Flow
7
4
-12
-34
- -
-24
-12
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Firm
7
4
- -
- -
- -
- -
- -
Free Cash Flow to Equity
- -
5
3
3
1
8
3
Free Cash Flow per Basic Share
0.4
0.43
-1.2
-1.91
0.01
-1.18
-0.51
Price/Free Cash Flow
- -
- -
7.01
5.21
10.26
13.6
-15.18
Cash Flow to Net Income
2.49
0.97
0.05
0.46
-1.36
0.62
1.09
Capital Expenditures
-2
-1
-10
-20
-5
-15
- -